Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Low affinity receptor for N-formyl-methionyl peptides. Additionally we are shipping FPR3 Proteins (5) and and many more products for this protein.
Showing 10 out of 101 products:
Human Polyclonal FPR3 Primary Antibody for ELISA, WB - ABIN4272913
Gao, Guillabert, Hu, Le, Urizar, Seligman, Fang, Yuan, Imbault, Communi, Wang, Parmentier, Murphy, Migeotte: F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor. in Journal of immunology (Baltimore, Md. : 1950) 2007
Human Monoclonal FPR3 Primary Antibody for CyTOF, FACS - ABIN4899077
Prevete, Liotti, Visciano, Marone, Melillo, de Paulis: The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis. in Oncogene 2015
The demonstrated proper folding and functionality of the cell-free produced human FPR3 opens a new avenue for the fast and efficient generation of human FPRs (and even other GPCRs) for structural and functional analysis.
The H. pylori-derived peptide Hp(2 (show DEFa3 Antibodies)-20) stimulated eosinophil migration through the engagement of FPR2 (show FPR2 Antibodies) and FPR3, and also induced production of VEGF-A (show VEGFA Antibodies) and TGF-beta (show TGFB1 Antibodies), two key mediators of tissue remodelling.
transcriptional variations of FPR3 occur by an alternative promoter during primate evolution.
F2L peptide, derived from the processing of nanomolar concentrations of heme-binding protein (HEBP)1 (show NFE2L2 Antibodies), is active on FPR3 and able to induce recruitment of FPR3-expressing monocytes, macrophages, and mouse neutrophils
N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2 (show FPR2 Antibodies)/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation.
Results show that uPAR (show PLAUR Antibodies) expression regulates the adhesive and migratory ability of CXCR4 (show CXCR4 Antibodies)-expressing cells through a mechanism involving fMLP (show FPR1 Antibodies) receptors and alpha-v integrins.
Human dendritic cells express functional FPRL2 throughout maturation. FPRL2 & its endogenous ligand may be involved in regulating DC trafficking during Ag uptake & processing s well as the T-cell-stimulating phase of the immune responses.
investigated the direct effect of LXA4 as well as the effect on agonist-induced biological responses using transfected HL-60 cells expressing FPR (show FPR1 Antibodies), FPRL1 (show FPR2 Antibodies) or FPRL2
an annexin 1 (show ANXA1 Antibodies) peptide can activate FPR (show FPR1 Antibodies), FPRL1 (show FPR2 Antibodies), and FPRL2; results indicate that annexin 1 (show ANXA1 Antibodies) participates in regulating leukocyte emigration into inflamed tissue by activating and desensitizing different receptors of the FPR (show FPR1 Antibodies) family.
Results show that humanin (HN) acts as a ligand for formyl peptide receptor-like 1 (FPRL1 (show FPR2 Antibodies)) and 2 (FPRL2).
ALOX5AP (show ALOX5AP Antibodies) Overexpression in Adipose Tissue Leads to LXA4 Production and Protection Against Diet-Induced Obesity and Insulin (show INS Antibodies) Resistance
antagonist pretreatment or gene silencing of the RvD1 receptor, ALX/FPR2 (show FPR2 Antibodies), abrogated the anti-inflammatory and pro-resolving actions of RvD1. These data indicate that RvD1 ameliorates IR-induced liver injury, and this protection is associated with enhancement of M2 polarization and efferocytosis via ALX/FPR2 (show FPR2 Antibodies) activation
The genome of at least 19 strains encodes a non-functional Fpr3 variant, whereas at least 13 other strains express an intact receptor. These results provide a foundation for understanding the in vivo function of Fpr3.
Compared with wild-type mice, Fpr2 (show FPR2 Antibodies)/3(-/-) animals exhibited exacerbation of disease severity, including hypothermia and cardiac dysfunction.
During ischemia, neutrophil Fpr2 (show FPR2 Antibodies)/3 controls platelet/neutrophil aggregates with the rapid generation of circulating LXA4, which in turn modulates downstream vascular inflammatory responses evident during the reperfusion phase.
the ligand profile of mFpr-rs1 (show RS1 Antibodies) is consistent with a role in vomeronasal pathogen sensing
lipoxin A(4)mediated the restoration of homeostasis of inflammation perpetuated by blocking COX-2 (show COX2 Antibodies) activity and PGE (show LIPF Antibodies)(2) production during resolution of collagen-induced arthritis
This homologue receptor shows 89% sequence identity with murine lipoxin A4 receptor (show FPR1 Antibodies) cDNA and functionally responds to LXA4 as a ligand.
Leukocyte antiadhesive and anti-inflammatory actions of annexin 1 (show ANXA1 Antibodies) involve this receptor.
Low affinity receptor for N-formyl-methionyl peptides. Receptor for lipoxin A4. May have an olfactory function associated with the identification of pathogens or of pathogenic states.
, FMLP-related receptor II
, N-formyl peptide receptor 3
, formyl peptide receptor-like 2
, FMLP-related receptor I
, LXA4 receptor
, N-formyl peptide receptor 2
, N-formylpeptide receptor-like 1
, formyl peptide receptor-like 1
, formyl peptide receptor-related sequence 1
, lipoxin A4 receptor
, N-formyl peptide receptor-like 2 receptor